| Members |
targetComponentId |
| Leptospirosis due to other specific organisms |
Leptospirosis |
| leptospirosis icterohemorrhagica |
Weil's disease |
| Leptospirosis icterohemorrhagica |
Weil's disease |
| Lepus victoriae |
Lepus microtis subspecies microtus (organism) |
| Letterer-Siwe's disease |
Langerhans cell histiocytosis, disseminated (morphologic abnormality) |
| sallat, livsmedel |
Lettuce (substance) |
| Leucaena glauca |
Leucaena leucocephala |
| leukodystrofi utan känd biokemisk grund |
Leucodystrophy |
| Leuconostoc fructosum |
Fructobacillus fructosus (organism) |
| Leuconostoc garviae |
Lactococcus garvieae (organism) |
| Leuconostoc oenos |
Oenococcus oeni |
| Leuconostoc paramesenteroides |
Weissella paramesenteroides |
| leukemi, kategori |
Leukaemia |
| leukemi |
Leukaemia |
| Leukemic reticuloendotheliosis |
Hairy cell leukemia |
| leukemisk retikuloendotelios, extranodal och/eller organlokaliserad |
Hairy cell leukemia |
| Leuprolide acetate 11.25mg |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
| Leuprolide acetate 11.25mg injection |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
| leuprorelinacetat 11,25 mg, pulver till injektionsvätska, suspension, flaska |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
| leuprorelinacetat 15 mg, pulver och vätska till injektionssuspension, flaska |
Leuprorelin only product in parenteral dose form |
| leuprolidacetat 15 mg, pulver till injektionsvätska, suspension, flaska |
Leuprorelin only product in parenteral dose form |
| Leuprolide acetate 22.5mg |
Leuprorelin only product in parenteral dose form |
| leuprorelinacetat 22,5 mg, pulver till injektionsvätska, suspension, flaska |
Leuprorelin only product in parenteral dose form |
| Leuprolide acetate 30mg |
Leuprorelin acetate 20 mg/mL suspension for injection |
| leuprorelinacetat 30 mg, pulver till injektionsvätska, suspension, flaska |
Leuprorelin acetate 20 mg/mL suspension for injection |
| leuprorelinacetat 45 mg, pulver till injektionsvätska, suspension, flaska |
Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
| Leuprolide acetate 7.5mg |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
| Leuprolide acetate 7.5mg injection |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
| leuprorelinacetat 7,5 mg, pulver till injektionsvätska, suspension, flaska |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
| Levafix svart |
Textile colours and finishes patch test substance |
| Levafix briljantblått |
Textile colours and finishes patch test substance |
| Levafix briljantgult |
Textile colours and finishes patch test substance |
| Levafix-färg |
Textile colours and finishes patch test substance |
| Levafix marinblått |
Textile colours and finishes patch test substance |
| levalbuterol 45 mikrogram, HFA-driven dosreglerad aerosolinhalator |
Product containing only levosalbutamol (medicinal product) |
| levobetaxololhydroklorid 0,5 %, suspension för oftalmiskt bruk |
Levobetaxolol 5 mg/mL eye suspension |
| levobunololhydroklorid 0,5 %, ögondroppar |
Levobunolol hydrochloride 5 mg/mL eye solution |
| levobunololhydroklorid 0,5 %, ögondroppar för engångsbruk |
Levobunolol hydrochloride 5 mg/mL eye solution |
| levobupivakain 1,25 mg/ml, injektionsvätska, lösning, påse 200 ml |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 1.25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| levocetirizin 2,5 mg/5 ml, oral lösning |
Levocetirizine dihydrochloride 500 microgram/mL oral solution |
| levofloxacin 1,5 %, lösning för oftalmiskt bruk |
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
| levofloxacin 25 mg/ml, oral lösning |
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
| levofloxacin 5 mg/ml, infusionsvätska, lösning, flaska 100 ml |
Levofloxacin 5 mg/mL solution for injection |
| levofloxacin 5 mg/ml, lösning för oftalmiskt bruk |
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution |
| kalciumleukovorin 50 mg, pulver till injektionsvätska, flaska |
Levoleucovorin (as levoleucovorin calcium) 50 mg powder for solution for injection vial |
| levometadylacetathydroklorid 10 mg/ml, oral lösning |
Levomethadyl 10 mg/mL oral solution |
| levanorgestrel 0,015 mg/dag + estradiol 0,045 mg/dag, transdermalt system |
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch |
| levonorgestrel 52 mg, intrauterint system |
Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) |
| Levothyroxine sodium 0.05mg tablet |
Levothyroxine sodium anhydrous 50 microgram oral tablet |
| Levothyroxine sodium 0.075mg tablet |
Levothyroxine sodium anhydrous 75 microgram oral tablet |
| Levothyroxine sodium 0.1mg tablet |
Levothyroxine sodium anhydrous 100 microgram oral tablet |
| Levothyroxine sodium 200mg tablet |
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug) |
| Levothyroxine sodium o.05mg |
Levothyroxine sodium anhydrous 50 microgram oral tablet |
| Leydigcelltumör i testikel |
Leydig cell tumor of testis of uncertain behavior |
| Leydigcellstumör |
Leydig cell tumor of uncertain behavior (morphologic abnormality) |
| lichen sclerosus et atrophicus |
Lichen sclerosus |
| lichen sclerosus et atrophicus hos vulva |
Lichen sclerosus of vulva (disorder) |
| lichen sclerosus et atrophicus, bullös typ |
Lichen sclerosus bullous type (disorder) |
| Liddle's syndrome |
Pseudoprimary hyperaldosteronism (disorder) |
| lidokain 1 % + adrenalin 1:200 000, injektionsvätska, lösning, flaska 20 ml |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
| lidokain 1,5 %, injektionsvätska, lösning, flaska |
Lidocaine only product in parenteral dose form |
| lidokain 2 % + adrenalin 1:200 000, injektionsvätska, lösning, flaska 20 ml |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| lidokain 2,5 %, salva för lokalt bruk |
Lidocaine hydrochloride 25 mg/g cutaneous ointment |
| lidokain 2,5 % + prilokain 2,5 %, parodontal gel |
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
| lidokainhydroklorid 0,1 % + glukos 5 %, infusionsvätska, lösning, påse |
Product containing precisely lidocaine hydrochloride 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| lidokainhydroklorid 0,2 % + glukos 5 %, infusionsvätska, lösning, påse |
Lidocaine hydrochloride 2 mg/mL solution for injection |
| lidokainhydroklorid 0,4 % + glukos 5 %, infusionsvätska, lösning, påse |
Lidocaine only product in parenteral dose form |
| lidokainhydroklorid 0,5 %, injektionsvätska, lösning, ampull |
Lidocaine only product in parenteral dose form |
| lidokainhydroklorid 0,5 %, injektionsvätska, lösning, flaska |
Lidocaine only product in parenteral dose form |
| lidokainhydroklorid 0,6 % + glukos 5 %, infusionsvätska, lösning, påse |
Product containing precisely lidocaine hydrochloride 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| lidokainhydroklorid 1 %, injektionsvätska, lösning, ampull |
Lidocaine only product in parenteral dose form |
| Lidocaine hydrochloride 1% injection |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| lidokainhydroklorid 1 %, injektionsvätska, lösning, ampull |
Lidocaine only product in parenteral dose form |
| lidokainhydroklorid 1 %, injektionsvätska, lösning, steril ampull |
Lidocaine only product in parenteral dose form |
| lidokainhydroklorid 1 %, injektionsvätska, lösning, flaska |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| lidokainhydroklorid 1 % + adrenalin 1:100 000, injektionsvätska, lösning, flaska |
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
| lidokainhydroklorid 1 % + adrenalin 1:200 000, injektionsvätska, lösning, flaska |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
| lidokainhydroklorid 1,5 %, injektionsvätska, lösning, ampull |
Lidocaine only product in parenteral dose form |
| lidokainhydroklorid 1,5 % + adrenalin 1:200 000, injektionsvätska, lösning, flaska |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
| lidokainhydroklorid 10 % + adrenalin 0,1 %, jontoforetiskt plåster för lokalt bruk |
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
| Lidocaine hydrochloride 2% injection |
Lidocaine only product in parenteral dose form |
| lidokainhydroklorid 2 %, injektionsvätska, lösning, ampull 5 ml |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| lidokainhydroklorid 2 %, injektionsvätska, lösning, ampull |
Lidocaine only product in parenteral dose form |
| lidokainhydroklorid 2 %, injektionsvätska, lösning, flaska |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| lidokainhydroklorid 2 % + adrenalin 1:100 000, injektionsvätska, lösning, flaska |
Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| lidokainhydroklorid 2 % + adrenalin 1:200 000, injektionsvätska, lösning, flaska |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
| lidokainhydroklorid 2 % + adrenalin 1:500 000, injektionsvätska, lösning, flaska |
Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| lidokainhydroklorid 4 %, injektionsvätska, lösning, ampull |
Lidocaine hydrochloride 40 mg/mL solution for injection |
| lidokainhydroklorid 5 %, injektionsvätska, lösning |
Lidocaine only product in parenteral dose form |
| lidokainhydroklorid 5 % + glukos 7,5 %, injektionsvätska, lösning, flaska |
Lidocaine hydrochloride 50 mg/mL solution for injection |
| lidokainhydroklorid 0,5 % + adrenalin 1:200 000, injektion |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine hydrochloride+epinephrine 1%/1:100,000 injection |
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
| lidokainhydroklorid 2 % + adrenalin 1:80 000, cylinderampull |
Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| lidokainhydroklorid + adrenalin 4 %, näsdroppar |
Adrenaline and lidocaine only product |
| lidokainhydroklorid + adrenalin 4 %, näsdroppar utan konserveringsmedel |
Adrenaline and lidocaine only product |
| lidokainhydroklorid 4 % + fluoresceinnatrium 0,25 %, ögondroppar |
Fluorescein stain and lidocaine only product |
| lidokainhydroklorid 4 % + fluoresceinnatrium 0,25 %, ögondroppar för engångsbruk |
Fluorescein stain and lidocaine only product |
| ideatorisk apraxi |
Transcortical apraxia |
| lidokain 5 % + hydrokortisonacetat 0,275 %, salva |
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment |
| Lignocaine hydrochloride 1% injection(plastic amp) |
Lidocaine only product in parenteral dose form |
| Lignocaine hydrochloride+adrenaline 2%/1:200000 sterile wrapped injection |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
FHIR